Identification and characterization of two new human mu opioid receptor splice variants, hMOR-1O and hMOR-1X

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• The mouse mu opioid receptor (Oprm) gene exhibits extensive alternative splicing, with 14 variants identified.
• Currently, only one human Oprm splice variant, MOR-1A, has been documented.

Purpose of the Study:

• To identify and characterize novel splice variants of the human mu opioid receptor (Oprm) gene.
• To investigate the potential for complex alternative splicing in the human Oprm gene.

Main Methods:

• Identification and sequencing of full-length cDNA for novel splice variants.
• Northern blot analysis to detect variant expression in human cell lines and brain tissues.
• Binding assays using transfected cells to assess opioid selectivity.

Main Results:

• Two new human Oprm splice variants, hMOR-1O and hMOR-1X, were identified.
• hMOR-1O and hMOR-1X utilize alternative fourth exons (O and X, respectively).
• Both variants demonstrated high selectivity for mu opioids in binding assays.

Conclusions:

• The discovery of hMOR-1O and hMOR-1X represents the first human MOR-1 variants with novel exons.
• These findings suggest that complex alternative splicing of the Oprm gene, similar to that observed in mice, may also occur in humans.
• This expands our understanding of human mu opioid receptor diversity and function.